A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer

Hot Springs

Springdale

Los Angeles

Santa Rosa

Denver

Fort Collins

Wilmington

Tucker

Indianapolis

New Orleans

Baltimore

Detroit

Minneapolis

Robbinsdale

Latham

New York

Arlington

Dallas

Abingdon

Marshfield

Mendoza

Ciudad de Buenos Aires

Brasschaat

Edegem

Liège

Merksem

Ostend

Las Condes

Brest

Nice

Paris

Pessac

Rouen

Saint-Herblain

Tours

Vandœuvre-lès-Nancy

Frankfurt am Main

Augsburg

Berlin

Freiburg im Breisgau

Grobhansdorf

Hamburg

Heidelberg

Hofheim

Koin

Leipzig

München

Neustadt/Suedharz

Trier

Ulm

Budapest

Bangalore

Mumbai

Pune

Ludhiana

New Dehli

Rozzano

Perugia

Pisa

Ravenna

Roma

's-Hertogenbosch

Amsterdam

Arnhem

Groningen

Nieuwegien

Zwolle

Oslo

Otwock

Warsaw

Krakow-Nowa Huta

Wroclaw

Bayamón

Ponce

Cluj-Napoca

Moscow

Overport

Arcadia

Durban

Parklands

Tygerberg

Alicante

Badalona

Barcelona

Sabadell

Madrid

Palma de Mallorca

Oviedo

Valencia

Barakaldo

Zaragoza

Linköping

Lund

Stockhlom

Zurich

Taoyuan District

Taichung

Taipei

Hull

London

Southampton

Nottingham

Glasgow

Cardiff

Newcastle upon Tyne